Compound Detail
CHEMBL362315
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL362315 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | UFCXZXHZPWSXTE-UHFFFAOYSA-N |
4
Targets
4
Activities
1
Assay Types
0
PK Parameters
6
Publications
0
Known Names
Molecular Properties
347.4
MW (Da)
3.47
ALogP
6
HBA
1
HBD
70.8
PSA (Ų)
0.84
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 4 meas. best 5.8
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| MOLT-4 | IC50 | = | 1580.0 | nM | 5.8 | Concentration required to inhibit human T-lymphoblast Molt4/C8 cell line prolife... | 16005627 |
| CCRF-CEM | IC50 | = | 2150.0 | nM | 5.67 | Concentration required to inhibit human T-lymphoblast CEM cell line proliferatio... | 16005627 |
| L1210 | IC50 | = | 2240.0 | nM | 5.65 | Concentration required to inhibit murine leukemia L1210 cell line proliferation | 16005627 |
| FM3A | IC50 | = | 5680.0 | nM | 5.25 | Concentration required to inhibit murine mammary carcinoma FM3A cell line prolif... | 16005627 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 16005627 | 10.1016/j.bmcl.2005.06.022 | Tubulin beta chain | 2 |
| 16005627 | 10.1016/j.bmcl.2005.06.022 | L1210 | 1 |
| 16005627 | 10.1016/j.bmcl.2005.06.022 | FM3A | 1 |
| 16005627 | 10.1016/j.bmcl.2005.06.022 | MOLT-4 | 1 |
| 16005627 | 10.1016/j.bmcl.2005.06.022 | CCRF-CEM | 1 |
| 16005627 | 10.1016/j.bmcl.2005.06.022 | Beta tubulin | 1 |
Data from ChEMBL 36 via Core Engine